Diagnosis and treatment of lower extremity venous thromboembolism: a review
R Chopard, IE Albertsen, G Piazza - Jama, 2020 - jamanetwork.com
Importance Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to
112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from …
112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from …
16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends
Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …
[HTML][HTML] Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the …
Clarity and guidance is required with regard to the use of direct oral anticoagulants in
antiphospholipid syndrome (APS) patients, within the confines of the recent European …
antiphospholipid syndrome (APS) patients, within the confines of the recent European …
[HTML][HTML] Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
arterial and venous thrombotic manifestations and/or pregnancy-related complications in …
arterial and venous thrombotic manifestations and/or pregnancy-related complications in …
[HTML][HTML] Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant …
A Tripodi, H Cohen, KMJ Devreese - Journal of thrombosis and …, 2020 - Elsevier
Background The laboratory detection of lupus anticoagulants (LA) in anticoagulated patients
represents a challenge and there is no consensus on the types of assays/procedures to be …
represents a challenge and there is no consensus on the types of assays/procedures to be …
Long-term treatment of venous thromboembolism
The most important decision in the long-term treatment of venous thromboembolism (VTE) is
how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked …
how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked …
[HTML][HTML] The (non‐) sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
W Chayoua, H Kelchtermans, JC Gris… - Journal of Thrombosis …, 2020 - Elsevier
Background The antiphospholipid syndrome (APS) is characterized by thrombosis and/or
pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti …
pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti …
[HTML][HTML] Prevalence of confirmed antiphospholipid syndrome in 18‐50 years unselected patients with first unprovoked venous thromboembolism
Background Antiphospholipid syndrome (APS) is an acquired thrombophilia disorder with
prevalence not completely known in patients with first unprovoked venous thromboembolic …
prevalence not completely known in patients with first unprovoked venous thromboembolic …
Anti–Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study
S Zuily, B de Laat, F Guillemin… - The journal of …, 2020 - academic.oup.com
Background Antibodies binding to domain I of β2-glycoprotein I (aDI) and activated protein C
(APC) resistance are associated with an increased risk of thrombosis in cross-sectional …
(APC) resistance are associated with an increased risk of thrombosis in cross-sectional …
Managing thromboembolic risk in patients with hereditary and acquired thrombophilias
J Moran, KA Bauer - Blood, The Journal of the American …, 2020 - ashpublications.org
While we are now able to diagnose inherited thrombophilias in a substantial number of
patients with venous thromboembolism (VTE), the initial hope that their presence would …
patients with venous thromboembolism (VTE), the initial hope that their presence would …